SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Invitrogen IVGN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (62)10/27/2006 4:19:07 AM
From: idos   of 73
 
finance is not my strong side, you have a much better understanding of the figures. what i see is that Q3 loss is due to one-time charge (a goodwill impairment charge of $2.85 a share and 15 cents a share for stock options expensing). Other than that revenue rose 7% but analysts are not happy. I think a similar thing went on after Q2, stock fell as low as 56$ because it did not meet expectations. BTW, i got in then but sold later at 65$.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News